Travatan Related Clinical Trials
Study of Patient Use and Perception of the Travatan Dosing Aid [Completed]
Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan [Completed]
Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy [Completed]
24-Hour IOP Control With TTFC vs Travoprost When Both Are Given PM in Subjects With POAG [Completed]
Safety and IOP Lowering Efficacy of AL-6221 [Active, not recruiting]
Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers [Completed]
The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye [Recruiting]
Phase IV Study of TRAVATAN 0.004% in Subjects With Iris Pigmentation Changes [Recruiting]
Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension [Completed]
Efficacy Study of Travoprost APS Versus TRAVATAN [Recruiting]
Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT [Recruiting]
A Long-Term Safety Study of Once-Daily Travatan [Active, not recruiting]
Assessing Ocular Surface Changes After Changing Glaucoma Medications [Recruiting]
Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension [Recruiting]
Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension [Recruiting]
A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT) [Completed]
IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension [Completed]
Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z® [Recruiting]
Effects of Travoprost on Neovascular Glaucoma [Not yet recruiting]
Results of Mass Switch From Latanoprost to Travoprost [Recruiting]
Travoprost APS Versus Xalatan® in Ocular Surface Health [Recruiting]
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) [Completed]
A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension [Completed]
Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004% [Completed]
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma [Completed]
Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-Angle Glaucoma or Ocular Hypertension [Completed]
Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension [Completed]
Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension [Not yet recruiting]
Safety and Efficacy of Travoprost/Timolol BAC-Free [Recruiting]
Examination of Ocular Surface Effects With Administration of Travatan Z and Xalatan [Recruiting]
A Single Dose Comfort Comparison of Travoprost Bak Free 0.004% in One Eye Versus Latanoprost 0.005% in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension [Recruiting]
Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension [Recruiting]
Phase IV Randomised Double-Masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension [Recruiting]
Travoprost 0.004%/Timolol 0.5% Versus Timolol 0.5% in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension [Not yet recruiting]
Influence of Prostaglandins on Ocular Blood Flow in Glaucoma Patients [Completed]
Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health [Recruiting]
Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% [Completed]
A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension [Not yet recruiting]
IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy [Completed]
24-Hour IOP Control With Travoprost/Timolol Fixed Combination [Completed]
Ocular Surface Effects of Prostaglandin Analogues (PGAs) [Not yet recruiting]
A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension [Recruiting]
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [Completed]
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [Completed]
A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma [Recruiting]
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [Completed]
Argon Laser Peripheral Iridoplasty for Primary Angle Closure Glaucoma :A Randomised Controlled Trial [Recruiting]
1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT [Recruiting]
Adherence Assessment With Travalert Dosing Aid [Not yet recruiting]
Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues [Recruiting]
Visual Function Changes After Intraocular Pressure Reduction [Completed]
An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance [Completed]
Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients [Active, not recruiting]
How Similar Are Changes to the Surface of the Eye When Two Different Glaucoma Eye Drops Are Used? [Recruiting]
Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs [Completed]
DuoTrav APS Versus XALACOM® in Ocular Surface Health [Not yet recruiting]
|
